Darlene G. Skapura

Baylor College of Medicine — United States

Medicine · Health Sciences

19h-index2.2kcitations48works3.22yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cardiac electrophysiology and arrhythmias(18), Prostate Cancer Treatment and Research(16), Ion channel regulation and function(13), Cancer, Lipids, and Metabolism(9), Cardiomyopathy and Myosin Studies(8)

Publications48 total

1251 SERUM BIOMARKER SIGNATURE IS PREDICTIVE OF THE RISK OF HEPATOCELLULAR CANCER IN PATIENTS WITH CIRRHOSIS
Gastroenterology·2024· 1 cited
Su1168 SERUM LEVELS OF TOTAL BILE ACIDS ARE ASSOCIATED WITH AN INCREASED RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CIRRHOSIS. A PROSPECTIVE COHORT STUDY
Gastroenterology·2024
Abstract 3013: Alzheimer’s-linked gene BIN1: Unraveling its unexpected role as a tumor suppressor in prostate cancer and influence on androgen receptor signaling
Cancer Research·2024
Abstract 1704: Interplay of MITF and NCOA3 in orchestrating oncogenic transcriptional network in uveal melanoma
Cancer Research·2024
Abstract 2077: Exploring the multifaceted efficacy of de novo lipogenesis inhibitor in cancer therapy
Cancer Research·2024
Serum biomarker signature is predictive of the risk of hepatocellular cancer in patients with cirrhosis
Gut·2024· 18 citedOpen Access
Abstract A008: Elucidating the effects of the Alzheimer's disease associated gene BIN1 on cancer tumorigenesis
Cancer Research·2023
Abstract B069: SPOP loss places the prostate luminal epithelial cells at a selective disadvantage
Cancer Research·2023
Abstract 442: Developing a lipogenesis inhibitor for prostate cancer
Cancer Research·2023
Abstract 2580: Nuclear receptor coactivator 3 (NCOA3) fuels oncogenic pathways in uveal melanoma
Cancer Research·2023
Abstract 1705: <i>SPOP</i>: An essential gene for normal and prostate tumor cells
Cancer Research·2023
Abstract 3406: GATA2 a novel potential therapeutic target for treatment of neuroendocrine prostate cancer
Cancer Research·2023
Supplementary Figure from The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response
2023Open Access
Data from The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response
2023Open Access
Supplementary Data from The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response
2023Open Access
Supplementary Data from The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response
2023Open Access
Data from The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response
2023Open Access
Supplementary Figure from The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response
2023Open Access
The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response
Cancer Research·2022· 38 citedOpen Access
Abstract IA15: Development of Novel Models and Identification of Therapeutic Vulnerabilities in Highly Aggressive Prostate Cancer In African American Men
Cancer Epidemiology Biomarkers & Prevention·2020
page 1 of 3Next →

Frequent Co-authors

Xander H.T. Wehrens(22), Salma Kaochar(22), Cristian Coarfa(16), Jenny Deng(14), Christel M. Davis(13), Ralph J. van Oort(12), Nicholas Mitsiades(12), Michael Ittmann(12), Na Li(11), Erik A. Ehli(11), Sandra L. Grimm(10), Jin Na Shin(9), Dallin Lowder(9), Collin McColl(9), Kinza Rizwan(9), Matthew L. Freedman(9), Dobromir Dobrev(8), Jacob E. Berchuck(8), Amit K. Dash(8), Patricia Castro(8)